Skip to content
Home/Companies/Biotech/Baseimmune
Baseimmune

Baseimmune

Biotech·UK·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Baseimmune?

Baseimmune is a British Biotech company, currently owned by IQ Capital Partners since 2021.

Hand-verified · updated 2026-07-08

Open JSON · CC-BY
IQ Capital Partners
Investor
IQ Capital Partners
IQ Capital Fund III · 2018 · VC

Key facts

HQUK
SectorBiotech
StatusActive
Websitewww.baseimmune.co.uk

More from IQ Capital Fund III

Other portfolio companies in the same fund.

Trogenix
Trogenix
Active
BiotechUK· 2023
IONATE
Ionate
Active
ClimateTechUK· 2022
Tropic Biosciences
Tropic Biosciences
Active
AgTechUK· 2022
Cambridge GaN Devices
Cambridge GaN Devices
Active
Deep TechUK· 2021
Closed Loop Medicine
Closed Loop Medicine
Active
HealthTechUK· 2021
CybSafe
CybSafe
Active
CybersecurityUK· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Baseimmune?

Baseimmune is currently owned by IQ Capital Partners, through IQ Capital Fund III, since 2021.

When did IQ Capital Partners acquire Baseimmune?

IQ Capital Partners acquired Baseimmune in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue